{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T23:57:53Z","timestamp":1768953473477,"version":"3.49.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.1002\/ejhf.552","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T01:26:10Z","timestamp":1473038770000},"page":"1172-1174","source":"Crossref","is-referenced-by-count":1,"title":["Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Heart Failure and Atrial Fibrillation: Does Concomitant Kidney Disease Change our Practice?"],"prefix":"10.1093","volume":"18","author":[{"given":"Farhan","family":"Shahid","sequence":"first","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital , Birmingham ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Shantsila","sequence":"additional","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital , Birmingham ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital , Birmingham ,","place":["UK"]},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"2026011721160760800_ejhf552-bib-0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"2026011721160760800_ejhf552-bib-0002","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/clc.22337","article-title":"Acute heart failure: acute cardiorenal syndrome and role of aggressive decongestion","volume":"37","author":"Hanna","year":"2014","journal-title":"Clin Cardiol"},{"key":"2026011721160760800_ejhf552-bib-0003","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2010.12.013","article-title":"Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk","volume":"57","author":"Marinigh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721160760800_ejhf552-bib-0004","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":"Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making\u2014a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"2026011721160760800_ejhf552-bib-0005","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/eurheartj\/eht328","article-title":"Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial","volume":"34","author":"Apostolakis","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721160760800_ejhf552-bib-0006","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721160760800_ejhf552-bib-0007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"2026011721160760800_ejhf552-bib-0008","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1160\/TH15-02-0169","article-title":"Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists","volume":"114","author":"Ruiz-Ortiz","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0009","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1160\/TH15-06-0518","article-title":"The SAMe-TT2R2 score and quality of anticoagulation in AF: can we predict which patient benefits from anticoagulation?","volume":"114","author":"Fauchier","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1160\/TH14-09-0754","article-title":"Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin","volume":"114","author":"Kim","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0011","first-page":"465","article-title":"Evaluation of patients\u2019 attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"Lahaye","year":"2014","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0012","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ejhf.614","article-title":"Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment","volume":"18","author":"Hawkins","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721160760800_ejhf552-bib-0013","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1160\/TH15-06-0453","article-title":"A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system","volume":"114","author":"Villines","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0014","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1160\/TH15-06-0497","article-title":"Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation","volume":"114","author":"Seeger","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1160\/TH15-10-0840","article-title":"Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry","volume":"115","author":"Hecker","year":"2016","journal-title":"Thromb Haemost"},{"key":"2026011721160760800_ejhf552-bib-0016","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1160\/TH14-11-0954","article-title":"Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry","volume":"113","author":"Beyer-Westendorf","year":"2015","journal-title":"Thromb Haemost"},{"issue":"2","key":"2026011721160760800_ejhf552-bib-0017","doi-asserted-by":"crossref","first-page":"ii69","DOI":"10.1093\/europace\/euv198","article-title":"Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients with renal dysfunction","volume":"17","author":"Lee","year":"2015","journal-title":"Europace"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.552","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/9\/1172\/66382506\/eurjhf_18_9_1172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/9\/1172\/66382506\/eurjhf_18_9_1172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:16:45Z","timestamp":1768702605000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/9\/1172\/8423168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,5]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.552","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,9,1]]}}}